name,category,termsB-cell scaffold protein with ankyrin repeats 1,INTERPRO[450016208$IPR017893:DBB domain]
B-cell scaffold protein with ankyrin repeats 1,OMIM_DISEASE[520001949$Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus, 520002051$Genome-wide association study targeting systemic lupus erythematosus., 520004787$Systemic lupus erythmatosus, association with]
B-cell scaffold protein with ankyrin repeats 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000153$b-cell activation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001478$systemic lupus erythematosus]
B-cell scaffold protein with ankyrin repeats 1,UP_SEQ_FEATURE[850007064$chain:B-cell scaffold protein with ankyrin repeats, 850103499$domain:DBB, 850112452$region of interest:Interaction with ITPR2, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
C-type lectin domain family 1, member B,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 1, member B,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 1, member B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
C-type lectin domain family 1, member B,UP_SEQ_FEATURE[850008703$chain:C-type lectin domain family 1 member B, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CDC42 small effector 1,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 1,SMART[760000256$SM00285:PBD]
CDC42 small effector 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 1,UP_SEQ_FEATURE[850010188$chain:CDC42 small effector protein 1, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850113403$region of interest:Mediates phosphoinositide-binding, 850118574$splice variant]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,INTERPRO[450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001331$ribosome biogenesis, 790001339$rna-binding, 790001345$rrna processing]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,UP_SEQ_FEATURE[850041119$chain:Probable ATP-dependent RNA helicase DDX56, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
FERM domain containing 6,INTERPRO[450000257$IPR000299:FERM domain, 450010818$IPR011993:Pleckstrin homology-type, 450012944$IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle, 450017249$IPR018979:FERM, N-terminal, 450017250$IPR018980:FERM, C-terminal PH-like domain, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
FERM domain containing 6,SMART[760000266$SM00295:B41]
FERM domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein]
FERM domain containing 6,UP_SEQ_FEATURE[850019182$chain:FERM domain-containing protein 6, 850102581$compositionally biased region:Poly-Ser, 850102584$compositionally biased region:Poly-Tyr, 850103760$domain:FERM, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
IKAROS family zinc finger 1 (Ikaros),COG_ONTOLOGY[90000073$General function prediction only]
IKAROS family zinc finger 1 (Ikaros),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
IKAROS family zinc finger 1 (Ikaros),OMIM_DISEASE[520002832$Leukemia, acute lymphoblastic]
IKAROS family zinc finger 1 (Ikaros),SMART[760000323$SM00355:ZnF_C2H2]
IKAROS family zinc finger 1 (Ikaros),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
IKAROS family zinc finger 1 (Ikaros),UP_SEQ_FEATURE[850015926$chain:DNA-binding protein Ikaros, 850102576$compositionally biased region:Poly-Leu, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850114251$region of interest:Required for binding PP1CC, 850114261$region of interest:Required for both high-affinity DNA binding and pericentromeric heterochromatin localization, 850117294$sequence conflict, 850118520$site:Required for both pericentromeric heterochromatin localization and complete DNA binding, 850118521$site:Required for both pericentromeric heterochromatin localization and DNA binding, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
NAD kinase,INTERPRO[450002223$IPR002504:ATP-NAD/AcoX kinase, 450015765$IPR017437:ATP-NAD kinase, PpnK-type, all-beta, 450015766$IPR017438:ATP-NAD kinase, PpnK-type, alpha/beta]
NAD kinase,KEGG_PATHWAY[470038796$hsa00760:Nicotinate and nicotinamide metabolism]
NAD kinase,PIR_SUPERFAMILY[630004861$PIRSF004914:ATP-NAD(H) kinase, 630030337$PIRSF500062:ATP-NAD(H) kinase, eukaryotic type]
NAD kinase,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000937$metal-binding, 790001006$nad, 790001008$nadp, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
NAD kinase,UP_SEQ_FEATURE[850033402$chain:NAD kinase, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
OTU domain, ubiquitin aldehyde binding 1,INTERPRO[450002899$IPR003323:Ovarian tumour, otubain, 450014937$IPR016615:Ubiquitin thioesterase Otubain, 450017638$IPR019400:Peptidase C65, otubain]
OTU domain, ubiquitin aldehyde binding 1,PIR_SUPERFAMILY[630011258$PIRSF013503:ubiquitin thioesterase Otubain, 630011259$PIRSF013503:Ubiquitin_thioesterase_Otubain]
OTU domain, ubiquitin aldehyde binding 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000763$immune response, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
OTU domain, ubiquitin aldehyde binding 1,UP_SEQ_FEATURE[850068041$chain:Ubiquitin thioesterase OTUB1, 850104870$domain:OTU, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118536$site:Required for proximal ubiquitin-binding, 850118574$splice variant, 850118575$strand, 850118624$turn]
SP100 nuclear antigen,BIOCARTA[30000234$h_pmlPathway:Regulation of transcriptional activity by PML]
SP100 nuclear antigen,INTERPRO[450000113$IPR000135:High mobility group, HMG1/HMG2, subgroup, 450000665$IPR000770:SAND, 450000793$IPR000910:High mobility group, HMG1/HMG2, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450004339$IPR004865:Sp100, 450009947$IPR010919:SAND-like, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
SP100 nuclear antigen,SMART[760000221$SM00249:PHD, 760000230$SM00258:SAND, 760000267$SM00297:BROMO, 760000349$SM00398:HMG]
SP100 nuclear antigen,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000315$chromosomal protein, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790000733$host-virus interaction, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001648$zinc]
SP100 nuclear antigen,UP_SEQ_FEATURE[850034808$chain:Nuclear autoantigen Sp-100, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102577$compositionally biased region:Poly-Lys, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850102921$DNA-binding region:HMG box 1, 850102922$DNA-binding region:HMG box 2, 850104153$domain:HSR, 850105253$domain:SAND, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117673$short sequence motif:PxVxL motif, 850118574$splice variant, 850118575$strand, 850118624$turn]
TERF1 (TRF1)-interacting nuclear factor 2,OMIM_DISEASE[520001589$Dyskeratosis congenita, autosomal dominant, 520004324$Revesz syndrome]
TERF1 (TRF1)-interacting nuclear factor 2,PIR_SUPERFAMILY[630030271$PIRSF038821:TERF1-interacting nuclear factor 2 (TINF2)]
TERF1 (TRF1)-interacting nuclear factor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000315$chromosomal protein, 790000356$complete proteome, 790000446$disease mutation, 790000476$dyskeratosis congenita, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001494$telomere]
TERF1 (TRF1)-interacting nuclear factor 2,UP_SEQ_FEATURE[850063842$chain:TERF1-interacting nuclear factor 2, 850106258$modified residue, 850114863$region of interest:TERF1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
THO complex 5,INTERPRO[450017409$IPR019163:THO complex,  subunit 5]
THO complex 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000988$mrna processing, 790000989$mrna splicing, 790000990$mRNA transport, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001558$transport]
THO complex 5,UP_SEQ_FEATURE[850064317$chain:THO complex subunit 5 homolog, 850106258$modified residue, 850112220$region of interest:Interaction with CSF1R, 850112946$region of interest:Interaction with THOC7, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
ataxin 2-like,INTERPRO[450008698$IPR009604:LsmAD domain, 450008904$IPR009818:Ataxin-2, C-terminal]
ataxin 2-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790000953$methylation, 790001162$phosphoprotein]
ataxin 2-like,UP_SEQ_FEATURE[850006400$chain:Ataxin-2-like protein, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850112554$region of interest:Interaction with MPL, 850117294$sequence conflict, 850118574$splice variant]
baculoviral IAP repeat-containing 6,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450001214$IPR001370:Proteinase inhibitor I32, inhibitor of apoptosis, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
baculoviral IAP repeat-containing 6,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
baculoviral IAP repeat-containing 6,SMART[760000185$SM00212:UBCc, 760000210$SM00238:BIR]
baculoviral IAP repeat-containing 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000109$Apoptosis, 790000356$complete proteome, 790000859$ligase, 790001162$phosphoprotein, 790001253$protease inhibitor, 790001510$thiol protease inhibitor, 790001593$ubl conjugation pathway]
baculoviral IAP repeat-containing 6,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850007258$chain:Baculoviral IAP repeat-containing protein 6, 850102565$compositionally biased region:Poly-Ala, 850105852$helix, 850106258$modified residue, 850114998$region of interest:Ubiquitin-conjugating, 850115712$repeat:BIR, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
bone morphogenetic protein receptor, type IA; similar to ALK-3,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes]
bone morphogenetic protein receptor, type IA; similar to ALK-3,INTERPRO[450000401$IPR000472:TGF-beta receptor/activin receptor, type I/II, 450000618$IPR000719:Protein kinase, core, 450003165$IPR003605:TGF beta receptor, GS motif, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
bone morphogenetic protein receptor, type IA; similar to ALK-3,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038850$hsa04350:TGF-beta signaling pathway]
bone morphogenetic protein receptor, type IA; similar to ALK-3,OMIM_DISEASE[520001016$chromosome 10q23 deletion syndrome, 520001251$Cowden-like syndrome, 520002704$Juvenile polyposis syndrome, infantile form, 520004050$Polyposis syndrome, hereditary mixed, 2, 520004052$Polyposis, juvenile intestinal]
bone morphogenetic protein receptor, type IA; similar to ALK-3,SMART[760000412$SM00467:GS]
bone morphogenetic protein receptor, type IA; similar to ALK-3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000825$kinase, 790000899$magnesium, 790000906$manganese, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001388$serine/threonine-protein kinase, 790001405$signal, 790001547$transferase, 790001555$transmembrane]
bone morphogenetic protein receptor, type IA; similar to ALK-3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850008231$chain:Bone morphogenetic protein receptor type- 1A, 850102883$disulfide bond, 850104083$domain:GS, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,INTERPRO[450007705$IPR008428:Chondroitin N-acetylgalactosaminyltransferase]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,UP_SEQ_FEATURE[850011240$chain:Chondroitin sulfate N- acetylgalactosaminyltransferase 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105986$metal ion-binding site:Divalent metal cation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
cytospin B,INTERPRO[450001520$IPR001715:Calponin-like actin-binding]
cytospin B,SMART[760000025$SM00033:CH]
cytospin B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene]
cytospin B,UP_SEQ_FEATURE[850014118$chain:Cytospin-B, 850102597$compositionally biased region:Ser-rich, 850103317$domain:CH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
damage-specific DNA binding protein 2, 48kDa,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
damage-specific DNA binding protein 2, 48kDa,KEGG_PATHWAY[470038823$hsa03420:Nucleotide excision repair, 470038836$hsa04115:p53 signaling pathway, 470038837$hsa04120:Ubiquitin mediated proteolysis]
damage-specific DNA binding protein 2, 48kDa,OMIM_DISEASE[520005124$Xeroderma pigmentosum, group E, DDB-negative subtype]
damage-specific DNA binding protein 2, 48kDa,SMART[760000289$SM00320:WD40]
damage-specific DNA binding protein 2, 48kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001643$xeroderma pigmentosum]
damage-specific DNA binding protein 2, 48kDa,UP_SEQ_FEATURE[850015526$chain:DNA damage-binding protein 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114335$region of interest:Required for interaction with DDB1, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117295$sequence variant, 850117429$short sequence motif:DWD box, 850118574$splice variant, 850118575$strand, 850118624$turn]
dermokine,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
dermokine,UP_SEQ_FEATURE[850014922$chain:Dermokine, 850102517$compositionally biased region:Gly-rich, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
family with sequence similarity 155, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
family with sequence similarity 155, member A,UP_SEQ_FEATURE[850066307$chain:Transmembrane protein FAM155A, 850102570$compositionally biased region:Poly-Gln, 850102573$compositionally biased region:Poly-Gly, 850105770$glycosylation site:N-linked (GlcNAc...), 850118623$transmembrane region]
family with sequence similarity 55, member B,OMIM_DISEASE[520000048$A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study]
family with sequence similarity 55, member B,PIR_SUPERFAMILY[630010122$PIRSF011875:pirsf011875]
family with sequence similarity 55, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 55, member B,UP_SEQ_FEATURE[850046012$chain:Protein FAM55B, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
fms-related tyrosine kinase 3 ligand,INTERPRO[450003721$IPR004213:Flt3 ligand, 450011046$IPR012351:Four-helical cytokine, core]
fms-related tyrosine kinase 3 ligand,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
fms-related tyrosine kinase 3 ligand,PIR_SUPERFAMILY[630012510$PIRSF015744:Fms-related tyrosine kinase 3 ligand/SL cytokine]
fms-related tyrosine kinase 3 ligand,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
fms-related tyrosine kinase 3 ligand,UP_SEQ_FEATURE[850060940$chain:SL cytokine, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
hepatopoietin PCn127; acidic (leucine-rich) nuclear phosphoprotein 32 family, member A,BIOCARTA[30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway]
hepatopoietin PCn127; acidic (leucine-rich) nuclear phosphoprotein 32 family, member A,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003163$IPR003603:U2A'/phosphoprotein 32 family A, C-terminal]
hepatopoietin PCn127; acidic (leucine-rich) nuclear phosphoprotein 32 family, member A,PIR_SUPERFAMILY[630014168$PIRSF017414:acidic leucine-rich nuclear phosphoprotein 32 family member A]
hepatopoietin PCn127; acidic (leucine-rich) nuclear phosphoprotein 32 family, member A,SMART[760000392$SM00446:LRRcap]
hepatopoietin PCn127; acidic (leucine-rich) nuclear phosphoprotein 32 family, member A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000853$leucine-rich repeat, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
hepatopoietin PCn127; acidic (leucine-rich) nuclear phosphoprotein 32 family, member A,UP_SEQ_FEATURE[850003457$chain:Acidic leucine-rich nuclear phosphoprotein 32 family member A, 850102468$compositionally biased region:Asp/Glu-rich (highly acidic), 850105852$helix, 850106258$modified residue, 850112285$region of interest:Interaction with E4F1, 850113719$region of interest:Necessary for tumor-suppressive function, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850117294$sequence conflict, 850118575$strand]
hypothetical protein LOC100130311,SP_PIR_KEYWORDS[790000356$complete proteome]
hypothetical protein LOC100130311,UP_SEQ_FEATURE[850074970$chain:Uncharacterized protein FLJ46558]
polymeric immunoglobulin receptor,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
polymeric immunoglobulin receptor,KEGG_PATHWAY[470038874$hsa04672:Intestinal immune network for IgA production]
polymeric immunoglobulin receptor,OMIM_DISEASE[520002600$IgA nephropathy, susceptibility to]
polymeric immunoglobulin receptor,SMART[760000357$SM00409:IG]
polymeric immunoglobulin receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000769$immunoglobulin receptor, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001545$transcytosis, 790001555$transmembrane, 790001556$transmembrane protein]
polymeric immunoglobulin receptor,UP_SEQ_FEATURE[850039911$chain:Polymeric immunoglobulin receptor, 850059176$chain:Secretory component, 850102883$disulfide bond, 850104408$domain:Ig-like V-type 1, 850104409$domain:Ig-like V-type 2, 850104410$domain:Ig-like V-type 3, 850104411$domain:Ig-like V-type 4, 850104412$domain:Ig-like V-type 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
pre-B-cell leukemia homeobox 4,INTERPRO[450001200$IPR001356:Homeobox, 450004996$IPR005542:PBX, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
pre-B-cell leukemia homeobox 4,OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
pre-B-cell leukemia homeobox 4,SMART[760000341$SM00389:HOX]
pre-B-cell leukemia homeobox 4,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
pre-B-cell leukemia homeobox 4,UP_SEQ_FEATURE[850040353$chain:Pre-B-cell leukemia transcription factor 4, 850102935$DNA-binding region:Homeobox; TALE-type, 850117294$sequence conflict, 850117295$sequence variant]
profilin family, member 4,INTERPRO[450001857$IPR002097:Profilin/allergen, 450004914$IPR005455:Profilin, plant]
profilin family, member 4,KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
profilin family, member 4,PIR_SUPERFAMILY[630002462$PIRSF002342:profilin]
profilin family, member 4,SMART[760000344$SM00392:PROF]
profilin family, member 4,SP_PIR_KEYWORDS[790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
profilin family, member 4,UP_SEQ_FEATURE[850044477$chain:Profilin-4]
similar to solute carrier family 35, member E2,INTERPRO[450004330$IPR004853:Protein of unknown function DUF250]
similar to solute carrier family 35, member E2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
similar to solute carrier family 35, member E2,UP_SEQ_FEATURE[850061443$chain:Solute carrier family 35 member E2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
spondin 2, extracellular matrix protein,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450008568$IPR009465:Spondin, N-terminal]
spondin 2, extracellular matrix protein,OMIM_DISEASE[520004444$Sequence Variants in the RNF212 Gene Associate with Genomewide Recombination Rate]
spondin 2, extracellular matrix protein,SMART[760000182$SM00209:TSP1]
spondin 2, extracellular matrix protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000763$immune response, 790000937$metal-binding, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
spondin 2, extracellular matrix protein,UP_SEQ_FEATURE[850062093$chain:Spondin-2, 850102883$disulfide bond, 850105381$domain:Spondin, 850105554$domain:TSP type-1, 850105756$glycosylation site:C-linked (Man), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850105986$metal ion-binding site:Divalent metal cation, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118272$site:Important for metal ion-dependent interaction with integrin, 850118575$strand, 850118624$turn]
tripartite motif-containing 5,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 5,PIR_SUPERFAMILY[630001870$PIRSF001733:tripartite motif-containing protein]
tripartite motif-containing 5,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX]
tripartite motif-containing 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000104$Antiviral defense, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000859$ligase, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 5,UP_SEQ_FEATURE[850066656$chain:Tripartite motif-containing protein 5, 850103078$domain:B30.2/SPRY, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118638$zinc finger region:B box-type, 850118911$zinc finger region:RING-type]
tudor and KH domain containing,INTERPRO[450002638$IPR002999:Tudor domain, 450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450007509$IPR008191:Maternal tudor protein, 450016411$IPR018111:K Homology, type 1, subgroup, 450016636$IPR018351:Tudor subgroup]
tudor and KH domain containing,SMART[760000291$SM00322:KH, 760000302$SM00333:TUDOR]
tudor and KH domain containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
tudor and KH domain containing,UP_SEQ_FEATURE[850067156$chain:Tudor and KH domain-containing protein, 850104521$domain:KH 1, 850104527$domain:KH 2, 850105583$domain:Tudor, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
vezatin, adherens junctions transmembrane protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001555$transmembrane]
vezatin, adherens junctions transmembrane protein,UP_SEQ_FEATURE[850100279$chain:Vezatin, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
